Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration-Reference-Cited by-同舟云学术

Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration

Published:2021-01-02 Issue:1 Volume:133 Page:1-9
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Freynhagen Rainer¹²,Baron Ralf³,Kawaguchi Yoshiharu⁴,Malik Rayaz A.⁵,Martire Diane L.⁶,Parsons Bruce⁷,Rey Roberto D.⁸⁹,Schug Stephan A.¹⁰,Jensen Troels Staehelin¹¹,Tölle Thomas R.¹²,Ushida Takahiro¹³,Whalen Ed⁶

Affiliation:

1. Center for Anaesthesiology, Intensive Care, Pain Medicine & Palliative Medicine, Benedictus Hospital, Feldafing, Germany

2. Department of Anaesthesiology, Technische Universtät München, Munich, Germany

3. Division of Neurological Pain Research and Therapy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

4. Department of Orthopaedic Surgery, Toyama University Hospital, Toyama, Japan

5. Weill Cornell Medicine, Qatar, Doha, Qatar

6. Pfizer Inc, New York, NY, USA

7. Viatris Inc., New York, NY, USA

8. Argentine Institute for Neurological Research (IADIN), Buenos Aires, Argentina

9. Neurology and Pain Department, Sanatorio Finochietto, Buenos Aires, Argentina

10. Anaesthesiology and Pain Medicine, Medical School, University of Western Australia, Perth, WA, Australia

11. Department of Neurology and Diabetic Neuropathy Consortium, Aarhus University Hospital, Aarhus, Denmark

12. Department of Neurology, Technische Universität München, Munich, Germany

13. Multidisciplinary Pain Center, Aichi Medical University Hospital, Nagakute, Japan

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2020.1857992

Reference85 articles.

1. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain

2. Burden of Illness Associated with Peripheral and Central Neuropathic Pain among Adults Seeking Treatment in the United States: A Patient-Centered Evaluation

3. Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy

4. Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study

5. Prevalence of chronic pain with neuropathic characteristics in the general population

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases;Progress in Molecular Biology and Translational Science;2024

2. A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain;Medicine;2023-04-25

3. A retrospective analysis of pain and opioid usage in head and neck free flap reconstruction;World Journal of Otorhinolaryngology - Head and Neck Surgery;2023-01-12

4. Diabetische Neuropathie und diabetischer Fuß (Update 2023);Wiener klinische Wochenschrift;2023-01

5. The effect of Pregabalin on the pain status of patients with disc and spinal surgeries: A systematic review of drug therapy;EURASIAN CHEM COMMUN;2022